Document Detail


Current assessment of endovascular therapy for infrainguinal arterial occlusive disease in patients with diabetes.
MedLine Citation:
PMID:  20804939     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Endovascular therapy (EVT) has increasingly become the initial clinical option for treatment of lower extremity peripheral arterial disease (PAD), not only for patients with claudication, but also for those with critical limb ischemia. Despite this major clinical practice paradigm shift, the outcomes of EVT for PAD are difficult to evaluate and compare with established surgical benchmarks because of the lack of prospective, randomized trials, incomplete characterization of indications for intervention, mixing of arterial segments and extent of disease treated, the multiplicity of EVT techniques used, the exclusion of early treatment failures, crossover to open bypass during follow-up, and the frequent lack of intermediate and long-term patency and limb salvage rates in life-table format. These data limitations are especially problematic when one tries to assess the outcome of EVT in patients with diabetes. The purpose of the present report is to succinctly review and objectively analyze available data regarding the results of EVT in patients with diabetes.
Authors:
Daniel M Ihnat; Joseph L Mills
Related Documents :
8076089 - Phlegmasia cerulea dolens: the role of non-operative therapy.
6845999 - Amputation for tumor of the upper arm.
10532219 - Long-term outcome in patients under 40 years after revascularization for chronic lower ...
3715719 - Successful conservative therapy of severe limb-threatening ischemia: the value of nonsy...
7804739 - Management of thrombosis in peripheral arterial disease.
3740359 - Effect of inflow and outflow sites on the results of tibioperoneal vein grafts.
7041149 - Late side effects related to inflatable breast prostheses containing soluble steroids.
24262059 - The most effective rescuer's position for cardiopulmonary resuscitation provided to pat...
8519519 - Reactive thrombocytosis after coronary bypass surgery. an important risk factor.
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Journal of vascular surgery     Volume:  52     ISSN:  1097-6809     ISO Abbreviation:  J. Vasc. Surg.     Publication Date:  2010 Sep 
Date Detail:
Created Date:  2010-08-31     Completed Date:  2010-09-27     Revised Date:  2012-10-03    
Medline Journal Info:
Nlm Unique ID:  8407742     Medline TA:  J Vasc Surg     Country:  United States    
Other Details:
Languages:  eng     Pagination:  92S-95S     Citation Subset:  IM    
Copyright Information:
Copyright © 2010 Society for Vascular Surgery and the American Podiatric Medical Association. Published by Mosby, Inc. All rights reserved.
Affiliation:
Division of Vascular Surgery, University of Arizona Health Sciences Center, Tucson, AZ 85724, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Amputation
Angioplasty* / adverse effects
Arterial Occlusive Diseases / physiopathology,  surgery,  therapy*
Constriction, Pathologic
Diabetic Angiopathies / physiopathology,  surgery,  therapy*
Femoral Artery
Humans
Ischemia / physiopathology,  surgery,  therapy*
Limb Salvage
Lower Extremity / blood supply*
Popliteal Artery
Recurrence
Tibial Arteries
Treatment Outcome
Vascular Patency

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Arterial imaging in patients with lower extremity ischemia and diabetes mellitus.
Next Document:  Challenges of distal bypass surgery in patients with diabetes: patient selection, techniques, and ou...